Search Results
You are viewing 1–12 of 95 results.
-
Between Publishing and Perishing? H5N1 Research Unleashes Unprecedented Dual-Use Research Controversy
May 3, 2012Recently, researchers in the Netherlands and the United States identified genetic mutations that could enable H5N1 bird flu to become easily transmissible from one human to another. Controversy has emerged about whether the details of these two particularly sensitive H5N1 studies should be openly published to aid global pandemic preparedness or withheld in the interests of national security. Because similar ...
Article | -
Prepared Testimony of Senator Nunn Regarding Biological Weapons Threat
July 23, 2001Testimony before the House Government Reform Committee's Subcommittee on National Security, Veterans Affairs and International Relations.
Testimony | -
Senator Nunn on ABC's World News Tonight
July 23, 2001John Yang interviews Senator Nunn about his participation in "Dark Winter" and America's readiness to withstand a bioterrorist attack.
Transcript | -
Harvard University Researcher Details New Vaccine Efforts
Oct. 8, 2003WASHINGTON — A researcher from Harvard University yesterday detailed her team’s efforts to create a new and more effective anthrax vaccine that could combat both the anthrax bacterium and the toxin it creates (see GSN, Sept. 3).
GSN Article | -
Harvard University Researcher Details New Vaccine Efforts
Oct. 8, 2003WASHINGTON — A researcher from Harvard University yesterday detailed her team’s efforts to create a new and more effective anthrax vaccine that could combat both the anthrax bacterium and the toxin it creates (see GSN, Sept. 3).
GSN Article | -
U.S. Researchers Produce Genetically Enhanced Mousepox
Oct. 31, 2003A team of U.S. researchers have created a genetically engineered mousepox virus that can evade vaccines, the Associated Press reported today (see GSN, Oct. 27).
GSN Article | -
First Ebola Vaccine Undergoing Human Trials In U.S.
Nov. 19, 2003The first volunteer in a pioneering Ebola vaccine trial received a synthetic replica of the deadly virus yesterday at the U.S. National Institutes of Health in Washington (see GSN, Aug. 7).
GSN Article | -
After 10-Year Effort, U.S. Has Much to Do to Improve WMD Defense, Conferees Say
Dec. 9, 2003WASHINGTON — The U.S. military still has a great deal to do to prevent and defend against WMD attacks from terrorists or foreign governments, according to a gathering of officials and experts marking the 10th anniversary of the founding of the Defense Department’s Defense Counterproliferation Initiative.
GSN Article | -
U.S. Scientists Successfully Test Ebola Vaccine On Mice
Dec. 10, 2003Scientists at the U.S. Army Medical Research Institute of Infectious Diseases have successfully immunized mice against the highly infectious Ebola disease, which has been viewed as a potential biological weapon, BBC News reported today (see GSN, Nov. 19).
GSN Article | -
Scientists Urge New Pentagon Agency to Restore Flagging Biological Defense Efforts
Jan. 23, 2004Saying that current U.S. military efforts to develop treatments and vaccines for potential biological weapon agents have “dismal prospects for successful results,” a group of top U.S. scientists yesterday urged the U.S. Defense Department to establish a new agency to consolidate the Pentagon’s multiple biological defense programs (see GSN, June 2, 2003; Vernon Loeb, Washington Post ...
GSN Article | -
U.S. Officials Anxiously Await Passage of Bioshield Bill
Jan. 26, 2004WASHINGTON — U.S. public health officials said Thursday that they anticipate Congress will soon pass the Project Bioshield legislation, a sweeping bill designed to strengthen the nation’s biological defenses and also loosen restrictions on hiring biological experts and the use of emergency drugs.
GSN Article | -
British Scientists Develop Bubonic Plague Vaccine
Feb. 19, 2004A vaccine for the bubonic plague, the bacteria that caused millions to die from the “Black Death” during the Middle Ages, may be available within the year as the result of a breakthrough at a British Defense Ministry laboratory, according to the London Times (see GSN, April 3, 2002).
GSN Article |
Refine Results by
Topic
- Biological (95)
- Biological Counterproliferation and Defense (95)
- Bio-Preparedness and Response (43)
- Medical Countermeasures (24)
- Viruses (22)
- Bacteria (18)
- Vaccine Stockpiles (13)
- Biological Terrorism (8)
- Bio-Surveillance (5)
- Chemical (5)
- Biological Weapons Programs (4)
- Biosecurity (4)
- Toxins (4)
- Nuclear (3)
- Preparedness and Response, Chemical (3)
- Public Health Systems (3)
- Nuclear Terrorism (2)
- Rapid Response to Infectious Diseases (2)
- Bio-engagement (1)
- Chemical Terrorism (1)
- Chemical Weapons Programs (1)
- Counterproliferation, Nuclear (1)
- Epidemic (1)
- Global Health Security (1)
- HEU Downblending (1)
- Health Diplomacy (1)
- Infectious Disease Detection (1)
- Lab Security (1)
- Medical Use of Radioactive Materials (1)
- Nuclear Materials Production, Consolidation, Elimination (1)
- Nuclear Nonproliferation, Arms Control, Disarmament (1)
- Peaceful Uses of Radioactive Materials (1)
- Preparedness and Response, Nuclear (1)
- Radiological/Radioactive (1)
- Terrorism (1)
Country/Region
- United States (62)
- United Kingdom (3)
- Canada (2)
- Russia (2)
- Australia (1)
- Austria (1)
- India (1)
- North Korea (1)
- South Korea (1)
Type
- GSN Article (91)
- Article (1)
- NTI News (1)
- Testimony (1)
- Transcript (1)
People
- Nunn, Sam (2)
- Tu, Michael (1)
